Home › Funds › Cormorant Asset Management, LP › ANL

Cormorant Asset Management, LP position in ANL

ADLAI NORTYE GROUP LTD · Health Care

Cormorant Asset Management, LP reported holding 3,978,229 shares of ANL (ADLAI NORTYE GROUP LTD) in its Q2 2026 13F filing — a position valued at US$45.7M, representing 2.34% of its reported portfolio and ranking #15 among its reported holdings. Cormorant Asset Management, LP has disclosed ANL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)3.98M sh
Reported value held$45.75M
Portfolio Weight2.34%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's ANL position evolved

Cormorant Asset Management, LP first disclosed a stake in ANL in Q1 2026 at 2,897,857 shares (US$20.1M). The position peaked in Q2 2026 at 3,978,229 shares, worth US$45.7M. Across 2 filings, Cormorant Asset Management, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,978,229 shares valued at US$45.7M — an increase of 1,080,372 shares quarter over quarter.. Notable position changes include a 37% increase in Q2 2026 (shares rose 39% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 2.90M $20.05M New
Q2 2026 3.98M $45.75M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANL and 13F data

ANL (ADLAI NORTYE GROUP LTD) is a Health Care company. 41 other funds we track also report a position in ANL — the largest reported positions include Venrock Adviser, LLC (US$36.9M), MPM BioImpact LLC (US$22.3M), Casdin Capital (US$14.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANL

All ANL fund holders →

FAQ

How long has Cormorant Asset Management, LP held ANL?

Cormorant Asset Management, LP has disclosed ANL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Cormorant Asset Management, LP's current position in ANL?

As of Q2 2026, Cormorant Asset Management, LP holds 3.98M shares of ANL (ADLAI NORTYE GROUP LTD), valued at $45.75M, representing 2.34% of its reported portfolio and ranking #15.

Has Cormorant Asset Management, LP been buying or selling ANL?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP increased its position in ANL. The position peaked in Q2 2026 at 3.98M shares.

Which other funds hold ANL?

Other major institutional holders of ANL include Venrock Adviser, LLC, MPM BioImpact LLC, Casdin Capital, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.